Maximising exclusivity for Academic Startups, Pharma and Biotech Companies in the Life Sciences
November 6, 2024 @ 11:00 – 12:00 CET
Welcome to this Drug Discovery Webinar, organized by OligoNova and SciLifeLab Drug Discovery and Development, to learn more about how academic and biotech interventions can be protected with the goal to benefit patients.
Join us for an insightful seminar focusing on strategies to maximize the exclusivity of medicinal products in the marketplace. This session will delve into the intricacies of regulatory intellectual property (IP), including patenting strategies, patent term extensions such as Supplementary Protection Certificates (SPCs), and regulatory exclusivities like data and market exclusivity. Additionally, we will explore further exclusivities available for orphan and paediatric medicines.
The seminar will emphasise the critical role of exclusivity in attracting and securing investor interest. Gain valuable knowledge on how to navigate and leverage these mechanisms to extend the market life of your medicinal products effectively, thereby enhancing their appeal to potential investors.
Agenda
- Introduction – Fredrik Wångsell, OligoNova
- Maximizing exclusivity in the Life Sciences – Fiona Hey, Tony Proctor and Michel Pears, Potter Clarkson
- Q&A and discussion
One follow-up webinar will take place later this year <ADD LINK>
Welcome
SciLifeLab DDD and OligoNova
Other Seminars
OligaNova organizes three seminars during the fall 2024
Trade secrets in the Life Sciences, October 15
Maximizing exclusivity in the Life Sciences, November 6
IP Strategies in the Life Sciences, December 18
par.matsson@oligonova.org
Google Calendar 
